A Year in Review: 2025
By
Substantial Research Progress and Fundraising Success
Pilot Recellularization Results
Confirming scaffold viability and cell growth
December Matching Campaign Success!
We crushed our goal! Thank you for raising nearly $60k with the match.
Scaling Up Recellularization, Unprecedented Biomechanics Data, and In Vivo Safety Testing
Larger samples, rigorous testing, and long-term safety data from our labs in Slovakia and Austria.
February 1st, 2026
From pilot success to full-scale protocols—plus, join Jan Kovac and William Musa for an exclusive bioreactor tour.
January 4th, 2026
$62,959 Raised: A Fundraising Win for the New Year!
May 2nd, 2023
More Progress with Sheep Trials and HistologiX
Sheep Trials: Successful Blood Vessel Formation and Scaffold Colonization
"It's a Fantastic Thing"
April 2nd, 2023
Roadmap to Animal Trials Completion
March 2nd, 2023
Perfecting technique on sheep
February 1st, 2023
Newsletter
A New Era for Foregen
Improved Governance Structure
Year in Review: 2022
Looking Back
Stakeholder Report #2: Sheep Trials
Animal Trials
5 Million Men? More Than Triple That: Over 18 Million American Men Would Consider Regenerating Their Foreskin.
YouGov Survey
.png)
.png)
.png)
.png)
Commentarium
by foregen